Business / Finance

RSS
Accellent first quarter net sales increase 1.3% to $131.6 million

Accellent first quarter net sales increase 1.3% to $131.6 million

Electromed third quarter net revenues decrease 8.2% to $4,774,000

Electromed third quarter net revenues decrease 8.2% to $4,774,000

MedNPV, SurgLine partner to supply low cost spinal orthopedic implants

MedNPV, SurgLine partner to supply low cost spinal orthopedic implants

Soligenix first quarter revenues decrease to $647,418

Soligenix first quarter revenues decrease to $647,418

Encision fourth quarter revenue increases to $3.370 million

Encision fourth quarter revenue increases to $3.370 million

Towers Watson signs agreement to acquire Extend Health

Towers Watson signs agreement to acquire Extend Health

3SBio first quarter total net revenues increase 24.5% to RMB147.2M

3SBio first quarter total net revenues increase 24.5% to RMB147.2M

Viewpoints: Two views on how to fight obesity; Tough choices for big business on health costs

Viewpoints: Two views on how to fight obesity; Tough choices for big business on health costs

Cigna to increase supplemental health insurance offerings with acquisition

Cigna to increase supplemental health insurance offerings with acquisition

N.J. Gov. vetoes bill creating health insurance exchange

N.J. Gov. vetoes bill creating health insurance exchange

IASIS Healthcare second quarter net revenue up 3.8% to $647.6M

IASIS Healthcare second quarter net revenue up 3.8% to $647.6M

Osiris Therapeutics first quarter total revenues decrease to $4.6M

Osiris Therapeutics first quarter total revenues decrease to $4.6M

Hooper Holmes first quarter consolidated revenues decline 4% to $38.8M

Hooper Holmes first quarter consolidated revenues decline 4% to $38.8M

Accretive readies response after query about latest business practices from Sen. Franken

Accretive readies response after query about latest business practices from Sen. Franken

Northstar Healthcare reports $0.6M net loss for first quarter 2012

Northstar Healthcare reports $0.6M net loss for first quarter 2012

Aradigm first quarter total revenue increases to $0.3 million

Aradigm first quarter total revenue increases to $0.3 million

PROLOR Biotech prices underwritten public offering of common stock

PROLOR Biotech prices underwritten public offering of common stock

Helix BioMedix first quarter revenue up 90% to $680,000

Helix BioMedix first quarter revenue up 90% to $680,000

iMedX acquires Accumed

iMedX acquires Accumed

Eisai, Arena announce expansion of lorcaserin marketing and supply agreement

Eisai, Arena announce expansion of lorcaserin marketing and supply agreement

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.